Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms.

× No keyword cloud information.

75 in total

Review 1. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues.

Authors: T M Tzschentke
Journal: Prog Neurobiol Date: 1998-12 Impact factor: 11.685

2. Brain-decarboxylase activities as indices of pathological change in senile dementia.

Authors: D M Bowen; P White; R H Flack; C B Smith; A N Davison
Journal: Lancet Date: 1974-06-22 Impact factor: 79.321

3. 4-aminotetrolic acid: new conformational-restricted analogue of -aminobutyric acid.

Authors: P M Beart; D R Curtis; G A Johnston
Journal: Nat New Biol Date: 1971-11-17

4. Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin: ocular safety pilot results.

Authors: Robert D Fechtner; Albert S Khouri; Emilia Figueroa; Marina Ramirez; Martha Federico; Stephen L Dewey; Jonathan D Brodie
Journal: Arch Ophthalmol Date: 2006-09

5. Design of a conformationally restricted analogue of the antiepilepsy drug Vigabatrin that directs its mechanism of inactivation of gamma-aminobutyric acid aminotransferase.

Authors: Sun Choi; Paola Storici; Tilman Schirmer; Richard B Silverman
Journal: J Am Chem Soc Date: 2002-02-27 Impact factor: 15.419

6. Suppression of elevated alanine aminotransferase activity in liver disease by vigabatrin.

Authors: A Williams; S Sekaninova; J Coakley
Journal: J Paediatr Child Health Date: 1998-08 Impact factor: 1.954

7. A multicentre study of vigabatrin for drug-resistant epilepsy.

Authors: T R Browne; R H Mattson; J K Penry; D B Smith; D M Treiman; B J Wilder; E Ben-Menachem; R M Miketta; K M Sherry; G K Szabo
Journal: Br J Clin Pharmacol Date: 1989 Impact factor: 4.335

8. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis.

Authors: L M Gunne; J E Häggström; B Sjöquist
Journal: Nature Date: 1984 May 24-30 Impact factor: 49.962

9. Synthesis, brain uptake, and pharmacological properties of a glyceryl lipid containing GABA and the GABA-T inhibitor gamma-vinyl-GABA.

Authors: J N Jacob; G W Hesse; V E Shashoua
Journal: J Med Chem Date: 1990-02 Impact factor: 7.446

10. New anticonvulsants: Schiff bases of gamma-aminobutyric acid and gamma-aminobutyramide.

Authors: J P Kaplan; B M Raizon; M Desarmenien; P Feltz; P M Headley; P Worms; K G Lloyd; G Bartholini
Journal: J Med Chem Date: 1980-06 Impact factor: 7.446

17 in total

1. Design and mechanism of tetrahydrothiophene-based γ-aminobutyric acid aminotransferase inactivators.

Authors: Hoang V Le; Dustin D Hawker; Rui Wu; Emma Doud; Julia Widom; Ruslan Sanishvili; Dali Liu; Neil L Kelleher; Richard B Silverman
Journal: J Am Chem Soc Date: 2015-03-30 Impact factor: 15.419

Review 2. Pathogenesis and new candidate treatments for infantile spasms and early life epileptic encephalopathies: A view from preclinical studies.

Authors: Aristea S Galanopoulou; Solomon L Moshé
Journal: Neurobiol Dis Date: 2015-05-09 Impact factor: 5.996

3. Mechanism of Inactivation of GABA Aminotransferase by (E)- and (Z)-(1S,3S)-3-Amino-4-fluoromethylenyl-1-cyclopentanoic Acid.

Authors: Hyunbeom Lee; Hoang V Le; Rui Wu; Emma Doud; Ruslan Sanishvili; John F Kellie; Phillip D Compton; Boobalan Pachaiyappan; Dali Liu; Neil L Kelleher; Richard B Silverman
Journal: ACS Chem Biol Date: 2015-07-06 Impact factor: 5.100

4. Rational Optimization of Mechanism-Based Inhibitors through Determination of the Microscopic Rate Constants of Inactivation.

Authors: Carter G Eiden; Kimberly M Maize; Barry C Finzel; John D Lipscomb; Courtney C Aldrich
Journal: J Am Chem Soc Date: 2017-05-18 Impact factor: 15.419

5. CPP-115, a vigabatrin analogue, decreases spasms in the multiple-hit rat model of infantile spasms.

Authors: Stephen W Briggs; Wenzhu Mowrey; Charles B Hall; Aristea S Galanopoulou
Journal: Epilepsia Date: 2013-10-28 Impact factor: 5.864

6. Synthesis and Deployment of an Elusive Fluorovinyl Cation Equivalent: Access to Quaternary α-(1'-Fluoro)vinyl Amino Acids as Potential PLP Enzyme Inactivators.

Authors: Christopher D McCune; Matthew L Beio; Jill M Sturdivant; Roberto de la Salud-Bea; Brendan M Darnell; David B Berkowitz
Journal: J Am Chem Soc Date: 2017-09-28 Impact factor: 15.419

7. Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase.

Authors: Ehud Zigmond; Ami Ben Ya'acov; Hyunbeom Lee; Yoav Lichtenstein; Zvi Shalev; Yoav Smith; Lidya Zolotarov; Ehud Ziv; Rony Kalman; Hoang V Le; Hejun Lu; Richard B Silverman; Yaron Ilan
Journal: ACS Med Chem Lett Date: 2015-05-29 Impact factor: 4.345

8. Design and Mechanism of (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic Acid, a Highly Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Addiction.

Authors: Jose I Juncosa; Kenji Takaya; Hoang V Le; Matthew J Moschitto; Pathum M Weerawarna; Romila Mascarenhas; Dali Liu; Stephen L Dewey; Richard B Silverman
Journal: J Am Chem Soc Date: 2018-01-30 Impact factor: 15.419

Review 9. Neonatal and Infantile Epilepsy: Acquired and Genetic Models.

Authors: Aristea S Galanopoulou; Solomon L Moshé
Journal: Cold Spring Harb Perspect Med Date: 2015-12-04 Impact factor: 6.915

10. Synthesis of ( S)-3-Amino-4-(difluoromethylenyl)-cyclopent-1-ene-1-carboxylic Acid (OV329), a Potent Inactivator of γ-Aminobutyric Acid Aminotransferase.

Authors: Matthew J Moschitto; Richard B Silverman
Journal: Org Lett Date: 2018-07-16 Impact factor: 6.005